|
Receptors | Cells | Biosensor | Key findings | Ref |
|
Dopamine D3 Muscarinic M1 | CHO-D3 CHO-M1 | DMR | Ligand pharmacology characterization | [98] |
|
β2-AR | A431 | DMR | Systems cell biology of the β2AR |
[99] |
Ligand-directed functional selectivity |
[100] |
Ligand-directed desensitization |
[101] |
|
PACAP1 | TM3 | RT-CES | PACAP agonists suppress the proliferation of immature mouse Leydig cell line TM3 | [102] |
|
CXCR2 | NIH-3T3-CXCR2 | ECIS | The role of CXCR2 in cell transformation | [103] |
|
Muscarinic M2 | CHO-M2 | DMR | Novel dualsteric M2 agonists |
[104] |
[105] |
|
Muscarinic M1 | CHO-M1 | DMR | HT screening identified novel M1 ligands | [106] |
|
GPR40/FFA1 | 1321N1-GPR40 HEK-GPR43 HEK-GPR41 HEK-GPR40 | DMR | Discovery of potent and selective agonists for FFA receptors | [107] |
GPR41/FFA3 | [108] |
GPR43/FFA2 | [109] |
|
Endogenous muscarinic receptor | HEK-293 | DMR | GPCR activation modulates Slack ion channel activity | [110] |
|
Cannabinoid CB2 | CHO-CB2 | RT- CES | Ligand pharmacology characterization |
[111] |
mGluR1 | CHO-mGluR1 |
|
Prostaglandin EP2 | C6G-EP2 HCT15-EP2 | DMR | Compound nanoparticles act as allosteric potentiators |
[112] |
|
mGluR7 | HEK-mGluR7 | DMR | Negative allosteric modulators | [113] |
|
GPR55 | HEK-GPR55 | DMR | GPR55 pleiotropic signaling | [114] |
|
Muscarinic M2 | CHO-M2 | DMR | Pathway deconvolution GPCR pleiotropic signaling Novel pathways for M3 |
[115] |
β2-AR | CHO-β2AR |
Muscarinic M3 | CHO-M3 |
GPR55 | HEK-GPR55 |
CRTH2 | HEK-CRTH2 |
EP2/3 | HEK-EP2/3 |
GPR40 | HEK-GPR40 |
EP receptors | HaCaT |
EP receptors | Keratinocytes |
|
Muscarinic M1 | CHO-M1 | CDS BIND DMR | Label-free reader comparison |
[116] |
Muscarinic M2 | CHO-M2 |
CRF | CHO-CRF |
MC4R | CHO-MC4R |
|
CRTH2 | HEK-CRTH2 | DMR | Novel function of CRTH2 C-terminal | [117] |
|
Mu opioid | CHO-MOR | DMR | Pathway deconvolution |
[118] |
Cannabinoid CB1 | CHO-CB1 |
Cannabinoid CB2 | CHO-CB2 |
Delta opioid | CHO-DOR |
|
PAR1 | A549 | DMR | Ligand-directed functional selectivity on receptor trafficking | [119] |
|
GPR35 | HT29 | DMR | Discovery of tyrphostins as GPR35 agonists | [120] |
|